We are requesting continuation funds for a research training program in the Pediatric Oncology Program at the Fred Hutchinson Cancer Research Center and the Department of Pediatrics, University of Washington. The purpose of the proposed program is to train promising physicians to become independent investigative pediatric oncologists. In the first year of the program, which is funded by sources other than this grant, trainees receive intensive exposure to clinical care and clinical research. In their second and third years, the trainees commit themselves to a major research effort. Research projects in the areas of hematopoietic stem cell transplant research, leukemia/lymphoma immunology and immunotherapy, transplantation biology, normal and malignant hematopoiesis, human immunogenetics, neuro-oncology, cancer survivorship and molecular genetics, as well as other programs are available.
The aim of the projects will be to contribute new and useful information relevant to pediatric oncology and to develop the research capabilities of the trainees to allow them to establish themselves as independent investigators. Physicians who have completed three years of training as residents in pediatrics will be eligible. Those most qualified and motivated to enter into investigative endeavors will be selected. In the past, many of the applicants have had previous laboratory experience. Of the thirty trainees supported by this NRSA who have completed their training during the past 15 years, 27 are in research positions: 21 in academic pediatric oncology, six in clinical trial development in industry. Three former trainees have clinical positions; one of whom has a pending academic appointment. We are requesting continued funding for two postdoctoral fellowships per year in a two-year program (a total of four positions). This program involves the laboratory and clinical research facilities of the Fred Hutchinson Cancer Research Center, Seattle Children's Research Institute, and the University of Washington. The clinical facilities of the Division of Pediatric Hematology-Oncology are located at Seattle Children's Hospital and the Seattle Cancer Care Alliance.
|Ketterl, Tyler G; Wu, David; Fromm, Jonathan R et al. (2018) Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemia. Bone Marrow Transplant 53:352-355|
|Taraseviciute, Agne; Tkachev, Victor; Ponce, Rafael et al. (2018) Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates. Cancer Discov 8:750-763|
|Ketterl, Tyler G; Dundas, Nicolas J; Roncaioli, Steven A et al. (2018) Association of Pre-pregnancy BMI and Postpartum Weight Retention Before Second Pregnancy, Washington State, 2003-2013. Matern Child Health J 22:1339-1344|
|Ketterl, Tyler G; Chow, Eric J; Leisenring, Wendy M et al. (2018) Adipokines, Inflammation, and Adiposity in Hematopoietic Cell Transplantation Survivors. Biol Blood Marrow Transplant 24:622-626|
|Sarthy, Jay; Zha, Ji; Babushok, Daria et al. (2018) Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype. Blood Adv 2:120-125|
|Cheung, Ronald S; Castella, Maria; Abeyta, Antonio et al. (2017) Ubiquitination-Linked Phosphorylation of the FANCI S/TQ Cluster Contributes to Activation of the Fanconi Anemia I/D2 Complex. Cell Rep 19:2432-2440|
|Kutny, M A; Alonzo, T A; Gamazon, E R et al. (2015) Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group. Leukemia 29:2424-6|
|Dahlberg, A; Woo, S; Delaney, C et al. (2015) Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity. Leukemia 29:1948-51|
|Carter, John H; Lenahan, Jennifer L; Ishak, Gisele E et al. (2015) Medical management of invasive fungal infections of the central nervous system in pediatric cancer patients. Pediatr Blood Cancer 62:1095-8|
|Hadland, Brandon K; Varnum-Finney, Barbara; Poulos, Michael G et al. (2015) Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells. J Clin Invest 125:2032-45|
Showing the most recent 10 out of 46 publications